Abbott Laboratories Announces Measurable Results From LATAM Diagnostic Market Development and Training Initiative Led by Claudia Marcela Riaño Caro
GEARWRENCH Continues to Redefine Automotive Diagnostics with Powerful New Tools
Tampa General’s Innovation Week Returns with New Programming to Showcase Breakthroughs in Patient Care and Technology
New England Biolabs ® Proudly Partners with Automation Providers to Support NGS Library Prep Automation Globally
Healthcare Triangle, Inc. Announces 1-for-60 Reverse Stock Split as Part of Nasdaq Compliance Plan
Juno Health Rated Highest Overall in Key "Future-Ready" Measures for Small and Rural Hospitals; RHT Program Funding Expected to Accelerate...
NAPLES, FL / ACCESS Newswire / February 3, 2026 / Stemtech Corporation, the global leader and pioneer in stem cell...
Clinical progress, pipeline expansion, and operational momentum underpin leadership continuity as the Company advances into 2026 and beyond SEATTLE, WA...
ESTERO, FL / ACCESS Newswire / February 3, 2026 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), wholly...
Company to Participate in BIO Partnering Summit and Present Phase 1 Ketamir-2 Data at American Association for Cancer Research (AACR)Annual...
With the global functional mushroom market projected to exceed $30+ billion and forecasted to grow at an estimated 9-12% CAGR,...
Access the “What This Means” segment here CAMBRIDGE, Mass., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), an industry...
Collaboration reinforces regulatory diligence, nonclinical strategy and clinical trial integrity for novel intranasal concussion therapy Traumatic brain injuries affect more...
GTB-5550 Phase 1 dose escalation basket trial expected to initiate mid-2026 Phase 1 protocol allows multiple solid tumor types known...
Oral presentation provides additional scientific rationale on Krabbe disease, one of four LSDs in the Phase 2 SOTERIA basket trial...
Next-generation therapeutic cancer vaccines in development for various oncology indications sold to NeoTrail Therapeutics with an undisclosed purchase priceNEW YORK...
Kennewick, WA, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) is pleased to provide shareholders with a positive...
New patent covers IBSRELA® and XPHOZAH® and expires in 2042WALTHAM, Mass., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq:...
Fort Pierce, FL, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Caring Brands Inc. (Nasdaq: CABR) today announced the issuance of two...
This clearance enables the next phase of development aimed ultimately at removing the adjunct use in the US The newly...
Company highlights accelerating access and revenue growth for ARBLI™ and confirms REZENOPY™ launch timeline, addressing a combined US annual losartan...
This is the first trial combining Allarity’s stenoparib with another anti-cancer agent Stenoparib’s favorable safety profile supports potential for...
A major regulatory milestone positioning Byonyks as a new entrant in home-based renal careCHICAGO, Feb. 03, 2026 (GLOBE NEWSWIRE) --...
Data represents up to 8.5 years of follow-up and are consistent across age, dose, and genotype BLA resubmitted to U.S....
Appointment reflects Beghou’s focus on scaling intelligently with integrated teams and technology to support clients throughout their commercialization journeyEVANSTON, Ill.,...
